Cargando…
Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies
Considerable scope exists to vary the physical and chemical properties of nanoparticles, with subsequent impact on biological interactions; however, no accelerated process to access large nanoparticle material space is currently available, hampering the development of new nanomedicines. In particula...
Autores principales: | Giardiello, Marco, Liptrott, Neill J., McDonald, Tom O., Moss, Darren, Siccardi, Marco, Martin, Phil, Smith, Darren, Gurjar, Rohan, Rannard, Steve P., Owen, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078733/ https://www.ncbi.nlm.nih.gov/pubmed/27767027 http://dx.doi.org/10.1038/ncomms13184 |
Ejemplares similares
-
Towards a rational design of solid drug nanoparticles with optimised pharmacological properties
por: Siccardi, Marco, et al.
Publicado: (2016) -
Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015) -
Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems
por: Liptrott, Neill J., et al.
Publicado: (2018) -
Nanomedicine‐Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy
por: Zhang, Zheng, et al.
Publicado: (2022) -
Advances in nanomedicine drug delivery applications for HIV therapy
por: Curley, Paul, et al.
Publicado: (2017)